“…In healthy astrocytes, subcellular AQP4 distribution is polarized and AQP4 is mainly located in the astrocyte endfeet surrounding blood vessels, where it functionally contributes to the blood-brain barrier and is involved in extracellular volume dynamics, water homeostasis and waste clearance (Nagelhus & Ottersen, 2013; Rasmussen, Mestre, & Nedergaard, 2022; Verkman, Smith, Phuan, Tradtrantip, & Anderson, 2017). We found increased AQP4 expression and loss of AQP4 polarization in all COVID-19 patients investigated, in contrast to a former study that showed decreased AQP4 (Rosu et al, 2022). Malfunction of AQP4 contributes to the progression of neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease, and AQP4 autoantibodies cause neuromyelitis optica spectrum disorder (Buccellato, D’Anca, Serpente, Arighi, & Galimberti, 2022; Mader & Brimberg, 2019; Nedergaard & Goldman, 2020; Pittock, Zekeridou, & Weinshenker, 2021).…”